Taste masking of naproxen sodium granules by fluid-bed coating

Pharmaceutical Development and Technology

Volumn 19, Issue 2, 2014, Pages 137-147

  Stange, Ulrike ^a   Führling, Christian ^b   Gieseler, Henning ^a,c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Niederbronner Pharmacy   (Germany)

^c GILYOS GmbH   (Germany)

Author keywords

Coating; Controlled release; Fluid bed; Taste masking

Indexed keywords

CITRIC ACID TRIETHYL ESTER; EUDRAGIT; NAPROXEN; PLASTICIZER;

AIRFLOW; ARTICLE; BATCH PROCESS; BITTER TASTE; CONTROLLED STUDY; DRUG COATING; DRUG GRANULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; FEMALE; FLUID BED COATING; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; MALE; MASKING; NORMAL HUMAN; PARTICLE SIZE; PRESSURE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SUSPENSION; TASTE; THERMOSTABILITY; X RAY POWDER DIFFRACTION;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; EXCIPIENTS; FEMALE; HUMANS; MALE; NAPROXEN; POLYMETHACRYLIC ACIDS; TASTE;

EID: 84896397295     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2012.757784     Document Type: Article

References (60)

1. Seager H. Drug-delivery products and the Zydis fast-dissolving dosage form. J Pharm Pharmacol 1998;50:375-82.
2. Gendolla A. Part I: What do patients really need and want from migraine treatment?. Curr Med Res Opin 2005;21:S3-7.
3. Guidance for Industry - Orally Disintegrating Tablets. FDA. 2008.
4. Shukla D, Chakraborty S, Singh S, Mishra B. Mouth dissolving tablets I: an overview of formulation technology. Sci Pharm 2009;77:309-26.
5. Brown D. Orally disintegrating tablets - taste over speed. Drug Deliv Tech 2003;3:1-5.
6. Evers S, May A, Fritsche G, et al. Acute treatment and prophylaxis of migraine. Nervenheilkunde 2008;10:933-49.
7. Sohi H, Sultana Y, Khar RK. Taste masking technologies in oral pharmaceuticals: recent developments and approaches. Drug Dev Ind Pharm 2004;30:429-48.
8. Sugiura T, Uchida S, Namiki N. Taste-masking effect of physical and organoleptic methods on peppermint-scented orally disintegrating tablet of famotidine based on suspension spray-coating method. Chem Pharm Bull 2012;60:315-19.
9. Hamashita T, Matsuzaki M, Ono T, et al. Granulation of core particles suitable for film coating by agitation fluidized bed II. A proposal of a rapid dissolution test for evaluation of bitter taste of ibuprofen. Chem Pharm Bull 2008;56:883-7.
10. Hamashita T, Nakagawa Y, Aketo T, Watano S. Granulation of core particles suitable for film coating by agitation fluidized bed I. Optimum formulation for core particles and development of a novel friability test method. Chem Pharm Bull 2007;55:1169-74.
11. Lehmann K, Petereit HU, Dreher D. Fast disintegrating controlledrelease tablets from coated particles. Pharm Ind 1993;55:940-7.
12. Mezaache D, Raiden MG, Sanghvi PP, Szedlock SJ (inventors); Fuisz Technologies Ltd (assignee). Dosage forms containing taste masked active agents patent US 6165512. 2000 Dec 26.
13. Shen R. Taste masking of ibuprofen by fluid bed coating. US Patent 5552152. 1996.
14. Shirai Y, Sogo K, Yamamoto K, et al. A novel fine granule system for masking bitter taste. Biol Pharm Bull 1993;16:172-7.
15. Taste Masking Formulations. Eudragit application guidelines: Evonik Röhm GmbH; 2009.
16. Kayumba PC, Huyghebaert N, Cordella C, et al. Quinine sulphate pellets for flexible pediatric drug dosing: formulation development and evaluation of taste-masking efficiency using the electronic tongue. Eur J Pharm Biopharm 2007;66:460-5.
17. Hoy MR, Roche EJ (inventors); Mcneil-Ppc, Inc. (assignee). Taste mask coatings for preparation of chewable pharmaceutical tablets patent US 5489436. 1996 Feb 6.
18. Shahzad Y, Shah SNH, Atique S, et al. The evaluation of coated granules to mask the bitter taste of dihydroartemisinin. Braz J Pharm Sci 2011;47:323-30.
19. Sugao H, Yamazaki S, Shiozawa H, Yano K. Taste masking of bitter drug powder without loss of bioavailability by heat treatment of wax-coated microparticles. J Pharm Sci 1998;87:96-100.
20. Kondo K, Niwa T, Ozeki Y, et al. Preparation and evaluation of orally rapidly disintegrating tablets containing taste-masked particles using one-step dry-coated tablets technology. Chem Pharm Bull 2011;59:1214-20.
21. Friend DR. Polyacrylate resin microcapsules for taste masking of antibiotics. J Microencapsul 1992;9:469-80.
22. Lai J-W, Qian KK, Venkatesh GM. Taste-masking pharmaceutical compositions prepared by coacervation. US Patent 11213266. 2006.
23. Mady FM, Abou-Taleb AE, Khaled KA, et al. Enhancement of the aqueous solubility and masking the bitter taste of famotidine using drug/SBE-beta-CyD/ Povidone K30 complexation approach. J Pharm Sci 2010;99:4285-94.
24. Szejtli J, Szente L. Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins. Eur J Pharm Biopharm 2005;61: 115-25.
25. Bora D, Borude P, Bhise K. Taste masking by spray-drying technique. AAPS Pharm Sci Tech 2008;9:1159-64.
26. Sollohub K, Janczyk M, Kutyla A, et al. Taste masking of roxithromycin by spray drying technique. Acta Pol Pharm 2011;68:601-4.
27. Yan YD, Woo JS, Kang JH, et al. Preparation and evaluation of taste-masked donepezil hydrochloride orally disintegrating tablets. Biol Pharm Bull 2010;33:1364-70.
28. Katsuragi Y, Mitsui Y, Umeda T, et al. Basic studies for the practical use of bitterness inhibitors: selective inhibition of bitterness by phospholipids. Pharm Res 1997;14:720-4.
29. Douroumis DD, Gryczke A, Schminke S. Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets. AAPS Pharm Sci Tech 2010;12:141-51.
30. Li SP, Martellucci SA, Bruce RD, et al. Evaluation of the filmcoating properties of a hydroxyethyl cellulose/hydroxypropyl methylcellulose polymer system. Drug Dev Ind Pharm 2002;28: 389-401.
31. Menjoge AR, Kulkarni MG (inventors); council of scientific and industrial research (assignee). Coating compositions for bitterness inhibition patent US 07294347. 2007 Nov 13.
32. Nguyen CA, Konan-Kouakou YN, Allemann E, et al. Preparation of surfactant-free nanoparticles of methacrylic acid copolymers used for film coating. AAPS Pharm Sci Tech 2006;7:1-7.
33. Pearnchob N, Siepmann J, Bodmeier R. Pharmaceutical applications of shellac: moisture-protective and taste-masking coatings and extended-release matrix tablets. Drug Dev Ind Pharm 2003;29: 925-38.
34. Cerea M, Zheng WJ, Young CR, McGinity JW. A novel powder coating process for attaining taste masking and moisture protective films applied to tablets. Int J Pharm 2004;279:127-39.
35. Sheshala R, Khan N, Darwis Y. Formulation and optimization of orally disintegrating tablets of sumatriptan succinate. Chem Pharm Bull 2011;59:920-8.
36. Jones RM. Particle size analysis by laser diffraction: ISO 13320, standard operating procedures, and Mie theory. Am Lab 2003;35: 44-7.
37. Vargas-Ubera J, Sanchez-Escobar JJ, Aguilar JF, Gale DM. Numerical study of particle-size distributions retrieved from angular light-scattering data using an evolution strategy with the Fraunhofer approximation. Appl Optics 2007;46:3602-10.
38. European Pharmacopoeia. Deutscher Apotheker Verlag and Govi-Verlag; 2012.
39. European Pharmacopoeia. Deutscher Apotheker Verlag and Govi-Verlag; 2011.
40. Davis SS, Hardy JG, Taylor MJ, et al. A comparative-study of the gastrointestinal transit of a pellet and tablet formulation. Int J Pharm 1984;21:167-77.
41. Jones D. Air suspension coating for multiparticulates. Drug Dev Ind Pharm 1994;20:3175-206.
42. Qi S, Gryczke A, Belton P, Craig DQM. Characterisation of solid dispersions of paracetamol and EUDRAGIT (R) E prepared by hotmelt extrusion using thermal, microthermal and spectroscopic analysis. Int J Pharm 2008;354:158-67.
43. Petereit HU, Weisbrod W. Formulation and process considerations affecting the stability of solid dosage forms formulated with methacrylate copolymers. Eur J Pharm Biopharm 1999;47:15-25.
44. Agarwal N, Farris RJ. Water absorption by acrylic-based latex blend films and its effect on their properties. J Appl Polym Sci 1999;72: 1407-19.
45. Bley O, Siepmann J, Bodmeier R. Importance of glassy-to-rubbery state transitions in moisture-protective polymer coatings. Eur J Pharm Biopharm 2009;73:146-53.
46. Carnaby-Mann G, Crary M. Pill swallowing by adults with dysphagia. Arch Otolaryngol Head Neck Surg 2005;131:970-5.
47. Gotoh H, Ogata H. Effect of the size of dosage forms on easiness of swallowing in healthy subjects and inpatients. Yakuzaigaku 1990;50:230-8.
48. Yamazaki N, Wada T, Sato K, et al. Effect of size and number of tablets on ease of swallowing. J Takeda Res Lab 1993;52:156-62.
49. Imai E, Hatae K, Shimada A. Oral perception of grittiness: effect of particle size and concentration of the dispersed particles and the dispersion medium. J Texture Stud 1995;26:561-76.
50. Engelen L, Van der Bilt A, Schipper M, Bosman F. Oral size perception of particles: effect of size, type, viscosity and method. J Texture Stud 2005;36:373-86.
51. Fu YR, Yang SC, Jeong SH, et al. Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies. Crit Rev Ther Drug Carrier Syst 2004;21:433-75.
52. Kibria G, Roni MA, Absar MS, Jalil RU. Effect of plasticizer on release kinetics of diclofenac sodium pellets coated with Eudragit RS 30 D. AAPS Pharm Sci Tech 2008;9:1240-6.
53. Sauer D, McGinity J. Properties of theophylline tablets dry powder coated with Eudragit (R) E PO and Eudragit (R) L 100-55. Pharm Dev Technol 2009;14:632-41.
54. Okada S, Tamemasa O. Distribution and metabolism of di-(N-butyl)- phathalate in mice and its interaction with nucleicacids and proteins. Yakugaku Zasshi-J Pharm Soc Jpn 1978;98: 1229-35.
55. Erden N, Celebi N. A study of the inclusion complex of naproxen with beta cyclodextrin. Int J Pharm (Kidlington) 1988;48:83-90.
56. Patel AR, Vavia PR. Preparation and evaluation of taste masked famotidine formulation using drug/beta-cyclodextrin/polymer ternary complexation approach. AAPS Pharm Sci Tech 2008;9: 544-50.
57. Ozturk AG, Ozturk SS, Palsson BO, et al. Mechanism of release from pellets coated with an ethylcellulose-based film. J Control Release 1990;14:203-13.
58. Voigt R, Wunsch G. The examination of drug release from filmcoated pellets under special consideration of the thickness of the polymer layer. DiePharmazie 1986;41:114-17.
59. Fischer R, Griffin F, Mead EL. Two characteristic ranges of taste sensitivity. Med Exp 1962;6:177-82.
60. Mahesh A, Shastri N, Sadanandam M. Development of taste masked fast disintegrating films of levocetirizine dihydrochloride for oral use. Curr Drug Deliv 2010;7:21-7.